The incidence of aberrant crypt foci and colonic carcinoma in dimethylhydrazine-treated rats varies in a site-specific manner and depends on tumor histology

Cancer Research

Volumn 57, Issue 20, 1997, Pages 4507-4510

  Park, Hyun Sook ^a   Goodlad, Robert A ^b   Wright, Nicholas A ^b  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DIMETHYLHYDRAZINE;

ADENOCARCINOMA; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLON CARCINOGENESIS; COLON CARCINOMA; INTESTINE CRYPT; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TUMOR LOCALIZATION;

ADENOCARCINOMA; ADENOMA; ANIMALS; CARCINOGENS; CARCINOMA; CECAL NEOPLASMS; COLON; COLONIC NEOPLASMS; DIMETHYLHYDRAZINES; MALE; RATS; RATS, WISTAR;

EID: 0030859476     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Fearon, E. R., and Vogelstein, B. A genetic model for colorectal tumorigenesis. Cell. 61: 759-767, 1990.
2. Miyaki, M., Seki, M., Okamoto, M., Yamanaka, A., Maeda, Y., Tanaka, K., Kikuchi, R., Iwama, T., Ikeuchi, T., Tonomura, A., Nakamura, Y., White, R., Miki, Y., Utsunomiya, J., and Koike, M. Genetic changes and histopathological types in colorectal tumors from patients with familial adenomatous polyposis. Cancer Res., 50: 7166-7173, 1990.
3. Morson, B. President's address. The polyp-cancer sequence in the large bowel. Proc. R. Soc. Med., 67: 451-457, 1974.
4. Muto, T., Bussey, H. J., Morson, B. C. The evolution of cancer of the colon and rectum. Cancer (Phila.), 36: 2251-2270, 1975.
5. Bird, R. P. Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings. Cancer Lett., 37: 147-151, 1987.
6. McLellan, E., and Bird, R. P. Effect of disulfiram on 1,2-dimethylhydrazine- and azoxymethane-induced aberrant crypt foci. Carcinogenesis (Lond.), 12: 969-972, 1991.
7. Pretlow, T. P., O'Riordan, M. A., Kolman, M. F., and Jurcisek, J. A. Colonie aberrant crypts in azoxymethane-treated F344 rats have decreased hexosaminidase activity. Am. J. Pathol., 136: 13-16, 1990.
8. Pretlow, T. P., Barrow, B. J., Ashton, W. S., O'Riordan, M. A., Pretlow, T. G., Jurcisek, J. A., and Stellato, T. A. Aberrant crypts: putative preneoplastic foci in human colonie mucosa. Cancer Res., 51: 1564-1567, 1991.
9. Pretlow, T. P., O'Riordan, M. A., Pretlow, T. G., and Stellato, T. A. Aberrant crypts in human colonie mucosa: putative preneoplastic lesions. J. Cell. Biochem. Suppl., 16G: 55-62, 1992.
10. Roncucci, L., Stamp, D., Medline, A., Cullen, J. B., and Bruce, W. R. Identification and quantification of aberrant crypt foci and microadenomas in the human colon. Hum. Pathol., 22: 287-294, 1991.
11. Cameron, I. L., Garza, J., and Hardman, W. E. Distribution of lymphoid nodules, aberrant crypt foci and tumours in the colon of carcinogen-treated rats. Br. J. Cancer, 73: 893-898, 1996.
12. Moen, C. J., van-der-Valk, M. A., Bird, R. P., Hart, A. A., and Demant, P. Different genetic susceptibility to aberrant crypts and colon adenomas in mice. Cancer Res., 56: 2382-2386, 1996.
13. Sunter, J. P., Appleton, D. R., Wright, N. A., and Watson, A. J. Pathological features of the colonic tumours induced in rats by the administration of 1,2-dimethylhydrazine. Virchows Arch. B Cell Pathol., 29: 211-223, 1978.
14. Sunter, J. P. Experimental carcinogenesis and cancer in the rodent gut. In: D. A. Appleton, J. P. Sunter, and A. J. Watson (eds.), Cell Proliferation in the Gastrointestinal Tract, pp. 255-277. London: Pitman Medical, 1980.
15. Oshima, M., Oshima, H., Kitagawa, K., Kobayashi, M., Itakura, C., and Taketo, M. Loss of Apc heterozygosity and abnormal tissue building in nascent intestinal polyps in mice carrying a truncated Apc gene. Proc. Natl. Acad. Sci. USA, 92: 4482-4486, 1995.
16. Luongo, C., Moser, A. R., Gledhill, S., and Dove, W. F. Loss of Apc+ in intestinal adenomas from Min mice. Cancer Res., 54: 5947-5952, 1994.
17. Hamilton, S. R. The adenoma-adenocarcinoma sequence in the large bowel: variations on a theme. J. Cell. Biochem. Suppl., 16G: 41-46, 1992.
18. Maskens, A. P., and Dujardin-Loits, R. M. Experimental adenomas and carcinomas of the large intestine behave as distinct entities: most carcinomas arise de novo in flat mucosa. Cancer (Phila.), 47: 81-89, 1981.
19. Ward, J. M. Dose response to a single injection of azoxymethane in rats. Induction of tumors in the gastrointestinal tract, auditory sebaceous glands, kidney, liver and preputial gland. Vet. Pathol., 12: 165-177, 1975.
20. Chang, W. W. Histogenesis of symmetrical 1,2-dimethylhydrazine-induced neoplasms of the colon in the mouse. J. Natl. Cancer Inst., 60: 1405-1418, 1978.
21. Chang, W. W. Morphological basis of multistep process in experimental colonic carcinogenesis. Virchows Arch. B Cell Pathol. Incl. Mol. Pathol., 41: 17-37, 1982.
22. Wiebecke, B., Krey, U., Lohrs, U., and Eder, M. Morphological and autoradiographical investigations on experimental carcinogenesis and polyp development in the intestinal tract of rats and mice. Virchows Arch. A Pathol. Anat., 360: 179-193, 1973.
23. Stopera, S. A., Murphy, L. C., and Bird, R. P. Evidence for a ras gene mutation in azoxymethane-induced colonic aberrant crypts in Sprague-Dawley rats: earliest recognizable precursor lesions of experimental colon cancer. Carcinogenesis (Lond.), 13: 2081-2085, 1992.
24. Pretlow, T. P. Aberrant crypt foci and K-ras mutations: earliest recognized players or innocent bystanders in colon carcinogenesis? Gastroenterology. 108: 600-603, 1995.
25. Smith, A. J., Stern, H. S., Penner, M., Hay, K., Mitri, A., Bapat, B. V., and Gallinger, S. Somatic APC and K-ras codon 12 mutations in aberrant crypt foci from human colons. Cancer Res., 54: 5527-5530, 1994.
26. Vivona, A. A., Shpitz, B., Medline, A., Bruce, W. R., Hay, K., Ward, M. A., Stern, H. S., and Gallinger, S. K-ras mutations in aberrant crypt foci, adenomas and adenocarcinomas during azoxymethane-induced colon carcinogenesis. Carcinogenesis (Lond.), 14: 1777-1781, 1993.
27. Yamashita, N., Minamoto, T., Ochiai, A., Onda, M., and Esumi, H. Frequent and characteristic K-ras activation and absence of p53 protein accumulation in aberrant crypt foci of the colon. Gastroenterology. 108: 434-440, 1995.
28. Heinen, C. D., Shivapurkar, N., Tang, Z., Groden, J., and Alabaster, O. Microsatellite instability in aberrant foci from human colons. Cancer Res., 56: 5339-5341, 1996.
29. Augenlicht, L. H., Richards, C., Corner, G., and Pretlow, T. P. Evidence for genomic instability in human colonic aberrant crypt foci. Oncogene, 12: 1767-1772, 1996.
30. Bird, R. P. Role of aberrant crypt foci in understanding the pathogenesis of colon cancer. Cancer Lett., 93: 55-71, 1995.
31. Otori, K., Sugiyama, K., Hasebe, T., Fukushima, S., and Esumi, H. Emergence of adenomatous aberrant crypt foci (ACF) from hyperplastic ACF with concomitant increase in cell proliferation. Cancer Res., 55: 4743-4746, 1995.